Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Extracellular activity of a bacterial protease associated with reduced phage infectivity

Abstract

To defend against bacteriophage (phage) infection, bacteria have developed various defense systems, dozens of which were discovered and mechanistically studied recently. To date, almost all defense systems whose mechanisms were deciphered were shown to operate within the bacterial cell. Here we describe a secreted protease from the Actinobacterium Salinispora mooreana which, when expressed heterologously in Streptomyces coelicolor, reduces titers of two taxonomically related Siphoviridae phages. Antiphage effects were maintained when concentrated supernatant from S. coelicolor expressing the Salinispora protease was added externally to phage-containing medium, in either the presence or absence of bacterial cells, supporting an extracellular mechanism. We further show that phages can escape the antiphage effect of the Salinispora protease by mutating a tail-associated protein. The antiphage effect is associated with an increased proportion of phage particles devoid of DNA. Our data suggest antiphage activity of a secreted bacterial protease.

Introduction

Over the past years, many immune systems that protect bacteria from bacteriophage (phage) infection were discovered and characterized [13]. Various mechanisms of defense were described, such as degradation of phage nucleic acids, regulated death of infected cells, inhibition of protein translation and DNA replication, and depletion of essential metabolites [4,5]. Most of the defense systems studied to date operate inside the bacterial cell after the phage has injected its DNA into the cell.

Previous studies have proposed that bacteria might use extracellular proteases to directly inactivate phage particles, but mechanistic studies to directly associate extracellular protease activity to an antiphage effect were limited. Hoque et al showed that incubation of Vibrio phages with spent media of Vibrio cholerae, exhibiting protease activity, led to decreased phage titers [6]. Castillo et al showed that incubation of phages in filtered supernatants from Vibrio anguillarum strains led to a reduction of up to 103-fold in phage titers [7]. This phage titer reduction was partially reversed by EDTA addition, supporting a potential proteolytic function. However, the identity of the putative proteases responsible for the proteolytic function was not determined [7].

Extracellular proteases have diverse roles in bacterial cell biology. For example, extracellular proteases from Clostridia are efficient collagenases; they enable these bacteria to colonize their host and are used clinically for treatment of collagen-related diseases [810]. Streptomyces griseus trypsin, encoded by the SprT gene, is an enzyme active at the onset of sporulation [11]. The production of another extracellular protease, with chymotrypsin-like activity in Streptomyces exfoliatus, was associated with mycelium formation and suggested to be important for the acquisition of proteinaceous nitrogen sources [12].

In this study, we report the identification of a bacterial gene coding for a putative extracellular protease from the Actinobacterium Salinispora mooreana, which exhibits an antiphage activity. Streptomyces coelicolor that heterologously expresses this protease can be infected by Streptomyces phages, but following replication and prolonged incubation, some phages lose infective titers by up to three orders of magnitude. The effect is specific for two homologous phages among a collection of S. coelicolor phages tested. The antiphage effect of the Salinispora protease is maintained when supernatant of S. coelicolor expressing the Salinispora protease is added externally to S. coelicolor cells not expressing the Salinispora protease, or incubated with phages in the absence of bacterial cells, supporting an extracellular activity of the secreted protease. By isolating mutant phages that can escape the antiphage effect of the Salinispora protease we identify a phage gene encoding for a structural protein that is repeatedly mutated in escaper phages. Our electron microscopy data suggest that the antiphage effect of the Salinispora protease is associated with counterproductive DNA ejection from affected phages.

Results

While examining putative gene cassettes predicted to encode antiphage pathways in bacteria from the genus Salinispora, we noticed a gene coding for a protease that was sometimes present next to various defense systems in these bacteria (Fig 1A). This gene caught our attention because its N-terminus was predicted to harbor a signal peptide, suggesting that it encodes for a secreted protease with extracellular proteolytic activity (Fig 1B). We decided to test the protease-encoding gene from Salinispora mooreana for antiphage defense. We chose S. coelicolor as the heterologous host to express this gene, because of its frequent use as a heterologous host for expressing genes derived from species of the Actinomycetota phylum, and because a variety of phages that infect this species were described [1417].

thumbnail
Fig 1. A secreted protease associated with reduced phage titers.

a. Genomic neighborhoods of a group of predicted secreted proteases (red) in Salinispora species. Genes known to be involved in bacterial antiphage defense are in yellow; other genes in grey. b. Position of a signal peptide in the Salinispora protease as predicted by the SignalP-6.0 software [13]. c. Titers of seven phages following infection with S. coelicolor expressing the WT Salinispora protease or an apramycin resistance gene used as a negative control. Phages were initially added at multiplicity of infection (MOI) of 0.05, and harvested from the culture two days from the onset of infection. Phages were then counted by plating on an indicator strain. Bars show the averages of three biological replicates with individual data point overlaid. d. Mass spectrometry (MS) analysis indicates presence of the protease in supernatants. Shown are non-redundant peptides (n = 60) detected using MS. S. coelicolor expressing the WT Salinispora protease was grown for 46 h, and the supernatant was harvested and filtered. Samples were digested with trypsin and were then subjected to protein MS. e. Titers of phage Alon following infection in the presence of protease-containing supernatant. WT or mutant protease-expressing S. coelicolor cells or cells not expressing the protease were grown for two days in the absence of phage, and supernatant was collected, filtered and concentrated. This supernatant was added to an infection experiment in liquid culture with S. coelicolor cells not expressing the protease and phage Alon at MOI = 0.1. Phages were then harvested from the culture two days after infection. Phage titer counts shown are averages of three biological replicates with individual data point overlaid. f. Titers of phage Alon following infection with S. coelicolor expressing the WT Salinispora protease (WT), a catalytically inactive protease mutant or an apramycin resistance gene instead of the protease as control. Phages were initially added at MOI = 0.1, and harvested from the culture two days from the onset of infection. Bars show the averages of three biological replicates with individual data point overlaid.

https://doi.org/10.1371/journal.pone.0332566.g001

To test whether the Salinispora protease has an antiphage effect, we performed infection experiments in liquid culture. S. coelicolor expressing the Salinispora protease, as well as control S. coelicolor not expressing the protease, were subjected to infection by a set of seven diverse S. coelicolor phages, some of which obtained from culture collections while others were isolated by us. We followed the dynamics of phage replication by taking samples from the liquid culture two days following phage addition, and used plaque assays on an indicator protease-less S. coelicolor to count phages. Following prolonged incubation for two days, the infective titers of phage Alon, but not any of the other phages, was reduced by three orders of magnitude when infecting the protease-expressing strain (Fig 1C).

The Salinispora protease was predicted by the SignalP-6.0 software to encode an N-terminal twin arginine translocation signal peptide of 34 amino acids with 99.9% likelihood [13]. We verified by protein mass spectrometry (MS) that the Salinispora protease is indeed found in the supernatant from a culture of S. coelicolor expressing the Salinispora protease (Fig 1D, S1 Table in S17 File). Peptides spanning the N-terminal signal peptide were depleted in these data, further supporting the hypothesis that this protease is secreted and the signal peptide is cleaved in the process (Fig 1D).

To test the hypothesis that the Salinispora protease exerts an antiphage activity extracellularly, we added concentrated supernatants from S. coelicolor expressing the Salinispora protease to media in which we performed infection experiments with phage Alon and S. coelicolor not expressing the protease. The results of this experiment demonstrated supernatant-dependent reduction in titers of phage Alon (Fig 1E).

To further substantiate that the proteolytic activity of the Salinispora protease is responsible for phage titer reduction, we substituted serine residue 219 in the protease, predicted to participate in the catalytic triad of the active site [1820], to alanine. This residue is found in the highly conserved GDSGGP motif of the catalytic triad [20]. Indeed, our data show that phage Alon infecting S. coelicolor cells that express the catalytically inactive S219A variant does not exhibit titer reduction (Fig 1F). In further support of this result, adding concentrated supernatant from S. coelicolor expressing the catalytically inactive S219A protease to media where infection experiments where performed with phage Alon and S. coelicolor lacking the protease, did not lead to phage titer reduction (Fig 1E). We verified that the S219A catalytically inactive Salinispora protease mutant expresses in S. coelicolor (Fig S1 in S1 File).

To gain further insight into the mechanism underlying the protease effect on phage titers, we attempted to isolate phage mutants that escape the effect of the protease. Such escaper mutants were previously shown useful for predicting the specificity determinants of bacterial defense systems [21]. We collected phages from an infection experiment in liquid culture of S. coelicolor expressing the Salinispora protease and subjected them to two additional rounds of infection with bacteria expressing the Salinispora protease. Isolated escapers showed a partial or complete resistance to the antiphage effect of the Salinispora protease (Fig 2A). We have not observed such phenotype in single plaques isolated from phage survivors of infections in the presence of mutant Salinispora protease (Fig 2A).

thumbnail
Fig 2. Phages escape the effect of the protease via mutations in a tail-associated gene.

a. Phage Alon variants selected on bacteria expressing the WT Salinispora protease (red) or catalytically inactive protease (blue). Results shown for a representative escaper mutant and control are averages of two biological replicates (two separately isolated escaper phages with the same genotype) with individual datapoints overlaid. Data for all phage Alon mutants that were isolated and sequenced are presented in Fig S3 and Table S2 in S1 File. b. Genome comparison of phage Alon and phage Tapuz. Amino acid sequence similarity in the range of 30%−100% is marked by grey shading. The gene mutated in all escapers is marked in green. Other genes with over 30% identity between the two phages are marked in red. Visualized using clinker [22]. c. Position of point mutations on the phage tail-associated protein, identified in phage mutants that escaped the effect of the protease. Domains are annotated according to a FoldSeek homolog search from the AlphaFold2 predicted structure [23,24], with CBM indicating carbohydrate binding module. Dark and light green mark the portion of the protein modeled in panels 2D and 2E, respectively. d. The C terminus of the protein mutated in phage Alon escapers is predicted by Alphafold2 to form hexamers (model ipTM = 0.79). The hexameric structure (dark green, amino acids 317-759) is structurally homologous (amino acids 589 through 716) to the tail tube protein of phage T4 (PDB code 5w5f, pink, one hexamer out of three hexamers presented in 5w5f is plotted for clarity). e. AlphaFold2 prediction of the N-terminus of the tail-associated protein (light green, amino acids 1 through 486) aligned with a homologous carbohydrate binding module (PDB code 3k4z, purple, amino acids 1 through 176).

https://doi.org/10.1371/journal.pone.0332566.g002

We sequenced the genome of 5 isolated escaper phages that were partially or wholly resistant to the antiphage effect of the Salinispora protease. As a control we sequenced the genomes of 3 phages selected in an infection experiment in liquid culture of bacteria expressing mutant protease. All 5 escapers isolated on strains expressing the WT protease had a mutation in the same phage gene (Fig 2B, Fig 2C), but none of the control phages had mutations in that gene (Table S2 in S1 File). Four of the escaper phages had an additional deletion that was also observed in control phages selected on bacteria expressing a mutant protease, suggesting that this deletion is unrelated to the escape phenotype (S2 Table in S1 File).

To test the robustness of the immune evasion phenotype of the escaper phages, we repeated this process also for a related phage called Tapuz, which shows 70% homology to phage Alon over 42% of its nucleotide sequence [25], and which we also found sensitive to the effect of the Salinispora protease (Fig S2 in S1 File). Two Tapuz phage mutants that can escape protease-mediated defense were isolated, and in both cases these phages exhibited a mutation in an orthologous gene in phage Tapuz, which shares 46% sequence identity with the protein mutated in the phage Alon escapers (Fig 2B, 2C). One of the escaper phages (escaper no. 6) did not contain any other mutation except for the mutation in the indicated gene, showing that this mutation is sufficient for the escaper phenotype (Table S2 in S1 File).

We predicted the structure of the mutated phage protein using AlphaFold2 in monomer and multimer forms [23] and ran a structural homology search using Foldseek [24]. The C-terminus of the protein (amino acids 589–716 in phage Alon) showed structural homology to the tail tube protein of phage T4 [26], suggesting that this protein may function as a tail-associated protein in phage Alon. Similar to the T4 tail tube, the AlphaFold2 model for the C-terminus of the phage Alon tail tube predicted high confidence (ipTM = 0.79) hexameric structure of a similar diameter to the phage T4 hexameric protein (Fig 2D). The N-terminus of the predicted tail tube protein of phage Alon exhibits three consecutive domains that are structurally similar to each other as well as to carbohydrate binding modules (Fig 2E).

Our data show that phages mutated in a predicted tail-associated protein can escape the effect of the Salinispora protease. To test the hypothesis that the antiphage effect of the Salinispora protease results from direct interaction with the phage particle, we incubated purified phage particles with concentrated supernatant from bacteria expressing the Salinispora protease. Phages incubated with the supernatant alone for one day showed 10-fold less infectivity as compared to phages incubated with a supernatant from bacteria expressing the mutated protease (Fig 3A). As with the antiphage effect in infection experiments in liquid culture, this bacteria-independent antiphage effect of the Salinispora protease was not observed in phages not homologous to phage Alon (Fig 3A).

thumbnail
Fig 3. The Salinispora protease is associated with Phage Alon titer reduction and DNA loss.

a. Incubation of phage particles with protease-containing supernatant results in titer loss. Phages Alon, Dagobah and Kromp were purified using CsCl gradient and incubated with concentrated supernatant from S. coelicolor cells expressing WT or catalytically inactive Salinispora protease. Phage titers shown are averages of three biological replicates with individual data points overlaid. b. Salinispora protease-dependent DNA-loss in phage Alon when incubated with concentrated supernatant from S. coelicolor cells expressing WT or catalytically inactive Salinispora protease. Particles were imaged under transmission electron microscopy and DNA content was recorded based on the observed density of the phage head. Graphs represent average percent of phages particles with DNA to total phage particles in counts of 300 particles per replicate. Shown is average of three replicates with individual data points overlaid. c. Salinispora protease-dependent DNA loss in phage Alon incubated with concentrated supernatant from S. coelicolor cells expressing WT Salinispora protease. Representative electron microscopy images of phages following treatment with concentrated supernatant from S. coelicolor expressing WT (c, left) or catalytically inactive S219A Salinispora protease (d, right). Black arrows point to phage particles with DNA and white arrows point to DNA-less “ghost” phage particles. Additional electron microscopy fields are presented in Fig S4 in S1 File.

https://doi.org/10.1371/journal.pone.0332566.g003

We next imaged the particles of phage Alon by transmission electron microscopy. Following incubation of the phages with concentrated supernatant obtained from protease-expressing bacteria, we observed that 90% of the phages contained “empty” heads, suggesting that these phages lost their DNA content (Fig 3B-D). In contrast, Alon phages incubated with supernatant obtained from bacteria expressing the mutated protease mostly exhibited DNA-containing heads (Fig 3B-D, Fig S4 in S1 File). These data suggest that phages incubated with protease-containing supernatant tend to have their DNA ejected, explaining the reduction in infectivity for these phages.

Discussion

In this study we demonstrate that a protease predicted to be secreted can affect the outcome of phage infection. When expressed in S. coelicolor, this Salinispora-originating protease is able to reduce infective titers of phages Alon and Tapuz after prolonged incubation, and we show that this activity is localized outside of the bacterial cell. The loss of phage infective titers was associated with increased ratios of phages that lost their DNA, suggesting that the protease causes loss of the DNA from affected phages. We furthermore found that phages mutated in a likely tail-associated protein can escape the effect of the protease.

One can envision several hypothetical mechanistic scenarios that can explain our observations. Under one hypothesis, cleavage of the structural protein in the phage tail leads to premature DNA ejection independent of the presence of bacteria, resulting in the observed DNA-less particles in the electron microscope. Within this hypothesis, escaper phages are resistant either to the direct proteolytic effect of the protease on the tail-associated protein or are able to maintain their DNA unejected even when their tail-associated protein is subjected to proteolysis.

An alternative hypothesis involving proteolysis is that the Salinispora protease cleaves off an extracellular portion of the bacterial protein used by the phage as a receptor. Within this hypothesis, the cleaved portion of the receptor protein is present in the supernatant derived from cells expressing the Salinispora protease, and the phage might bind it, thereby stimulating DNA ejection. Escaper phage mutants may have a reduced affinity to the phage receptor and require increased receptor concentration to lead to binding and DNA ejection. Phage T5, for example, is known to release its DNA in vitro in the presence of its bacterial receptor FhuA [27].

Our study has several limitations. First, it is possible that the primary role of the protease does not involve phage defense when expressed in its original Salinispora host. However, studies in the original bacteria encoding this protease are limited due to the slow growth rate of this marine bacterium in laboratory settings [28], as well as the absence of genetic systems and the lack of known phages for this host. While the protease we studied is located in variable genomic environments in Salinispora species, homologs of this protease in other bacteria do not tend to be enriched next to known defense systems in bacterial genomes, implying that this family of proteases have roles other than phage defense. It is therefore possible that the effect we observed when expressing this protease in S. coelicolor is a side effect of the real biological activity of the protease.

Another limitation of this study is that we worked with supernatants from protease-expressing cells rather than with a purified protease. While we demonstrated that supernatants contain the secreted protease, and that the antiphage activity we found in the supernatants is dependent on an intact protease active site, we cannot rule out that the activity we observed involves other factors. Unfortunately, we have not managed to purify this protease from E. coli cells. Future studies with purified proteases can examine whether the protease alone has a direct effect on premature DNA ejection from phage particles. In addition, future experiments with different growth media or expression conditions may lead to better expression outcomes.

A puzzling observation in our study is that phage Alon can readily infect and replicate on S. coelicolor cells even when these cells express the Salinispora protease (Fig S5 in S1 File). The reduction in infective titers is only observed after the phages, which already replicated, are further incubated with the cells (or the supernatant derived from these cells) for a prolonged period of two days. This can be explained in several ways. First, it is possible that the protease activity is very slow, and only affects the phages after long incubation. Second, it is possible that the antiphage activity necessitates another factor that is produced by Streptomyces cells only in a late developmental stage. It is known that Streptomyces species produce some secondary metabolites only after 2–3 days from spore germination [29], and in some cases even longer periods are required for the production of secondary metabolites [29,30].

Most bacterial defense systems investigated to date were heterologously expressed in E. coli or B. subtilis and originated from members of their respective phyla [13]. Recent studies showed that using expression hosts from the Actinomycetota phylum, and specifically Streptomyces bacteria, can lead to the discovery of new concepts in antiphage defense [3134]. Our study is an additional demonstration of the benefit of using Streptomyces to study bacterial defenses. As Actinomycetota often live in complex ecological environments and exhibit multicellularity characteristics, it might make sense that these bacteria would involve extracellular antiphage activity as part of their defensive arsenals. Further studies with Streptomyces may find additional such extracellular mechanisms in the future.

Materials and methods

Spore stocks of S. coelicolor and Streptomyces lividans strains were prepared as previously described [35]. Conjugation and genome integration of integrative plasmids into S. coelicolor was performed as previously described [36], with the following modification: pRK2013 [37] was used as the helper conjugation plasmid instead of pUB307. Phage infection experiments in liquid culture were performed in DNB MMC media, (Difco nutrient broth, supplemented with 10 mM MgCl2, 0.1 mM MnCl2 and 8 mM CaCl2) at 30°C in 15 mL culture tubes shaking at 350 rpm, unless specified otherwise. Phage sequence homology search was performed using blastn with the default search parameters [25]. Protein structure prediction from sequence was performed using AlphaFold2 [23]. Protein structural homolog search was performed using Foldseek [24]. Protein structures were visualized using PyMOL [38]. No permits were required for the described study, which complied with all relevant regulations.

Phage isolation from soil

Phages Alon, Tapuz and Zayit were isolated from soil following previously reported protocols [31], with modifications as described hereby: In a 15 mL culture tube, S. coelicolor M145 was added at a concentration of 5 × 106 CFU/mL to 5 mL of DNB with 0.5%(w/v) glucose and 4 mM CaCl2. 2 mL of soil were added as well and samples were incubated at 30°C overnight. Supernatant was collected by two rounds of centrifugation followed by filtration. The supernatant was serially diluted and plated on DNB to obtain single plaques as described below: 100 μL spore suspension of S. coelicolor M145 (108 CFU/ mL) were added to 15 mL screw cap tubes. 5 mL of DNB MMC with 0.5%(w/v) agar at 50°C were then added and the resulting phage/spore suspension was mixed and plated on 100 X 15 mm plates with 20 mL DNB 2%(w/v) agar. The plates were incubated overnight at 30°C. Single plaques were picked with a pipette tip into 120 μL phage buffer (50 mM Tris pH 7.4, 100 mM MgCl2, 10 mM NaCl). Two more rounds of plating for single plaque and picking ensued and then phages were amplified as described below, under ‘phage stocks preparation from single plaques’, to obtain the phage stock. Phage DNA sequencing was performed as previously described [21].

Phage stocks preparation from single plaques

To prepare phage stocks from single plaques, phage stocks were serially diluted, 20 μL into 180 μL, and added to a 100 μL spore suspension of S. coelicolor M145 (108 CFU/ mL) in 15 mL screw cap tubes. 5 mL of DNB MMC with 0.5%(w/v) agar at 50°C were then added and the resulting phage/spore suspension was mixed and plated on 100 × 15 mm plates with 20 mL DNB 2%(w/v) agar. The plates were incubated overnight at 30°C followed by incubation at 25°C until single plaques were visible, if necessary. Single plaques were picked with a pipette tip into 120 μL phage buffer.

To obtain confluent lysis, single plaque suspensions in phage buffer were serially diluted, 20 μL into 180 μL, in phage buffer and added to 100 μL spore suspension of S. coelicolor M145 (108 CFU/ mL) in 15 mL screw cap tubes. 5 mL of DNB MMC 0.5%(w/v) agar at 50°C were then added and the resulting phage/spore suspension was mixed and plated on 100 × 15 mm plates with 20 mL DNB 2%(w/v) agar.

Phage stocks were prepared from confluent lysis plates by scraping the 5 mL 0.5%(w/v) agar layer onto 6 mL DNB in 15 mL screw cap tubes, vortexing and shaking intermittently for 1 h at 25°C, followed by 15 min centrifugation at 3200 g at 4°C. The supernatant was then filtered through 0.2 μ filters and phage concentration was measured by plaque assay, as described below, under ‘phage titer measurement by plaque assay’.

Infection experiment of S. coelicolor with phages in liquid culture

Spores of S. coelicolor encoding WT Salinispora protease, mutant S219A Salinispora protease or no Salinispora protease (Table S3 in S1 File, strains 5–7) were added in biological triplicates to 750 μL of DNB MMC in culture tubes of 15 mL at a concentration of 3 × 107 CFU/mL, along with relevant phage in multiplicity of infection (MOI) of 0.1 and incubated for 45 h, unless otherwise indicated. Following incubation, phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters. Phage titer was then measured by plaque assay as described blow.

Phage titer measurement by plaque assay

Phage stocks were serially 10 × diluted, 20 μL to 180 μL, in phage buffer, to obtain 100-10-7 dilutions. A square petri dish of S. coelicolor M145 was prepared by mixing 30 mL of 50°C DNB MMC medium with 0.5%(w/v) agar with 106 CFU of M145 spores and left to cool for 1 h. Onto that plate, 10 μL of each phage dilution were dropped, left to dry for 1 h and placed in 30°C overnight, followed by incubation at 25°C until single plaques were visible, if necessary. Phage titer was calculated by counting individual plaques in the highest concentration dilution where single plaques are countable and multiplying by the corresponding dilution factor.

Supernatant harvest from S. coelicolor cultures

Spores of S. coelicolor encoding WT Salinispora protease, mutant S219A Salinispora protease or no Salinispora protease (Table S3 in S1 File, strains 5–7) were added in biological triplicates to 6 mL of DNB MMC at a concentration of 3 × 107 CFU/mL, equally divided to 2 culture tubes of 15 mL (3 mL in each tube) and incubated for 46 h. Following incubation, supernatants from each two duplicate tubes were combined and harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters. Larger molecules in the supernatant were then concentrated by transferring to Amicon® Ultra-4 10 KDa filters and centrifugation at 3200 g at 4°C for 60 min. Samples were then placed on ice until use for infection experiments in liquid culture and frozen at −20°C prior to supernatant analysis by protein MS.

Supernatant analysis by protein MS

Supernatant samples were subjected to in-solution tryptic digestion following the S-trap protocol (Protifi) followed by a solid phase extraction cleanup step. The resulting peptides were analyzed using nanoflow liquid chromatography (nanoAcquity) coupled to high resolution, high mass accuracy mass spectrometry (Thermo Q-Exactive HFX). The samples were analyzed on the instrument separately in a random order in discovery mode. Raw data was processed with the MetaMorpheus v1.0.2 informatics platform. The data were searched with semi-tryptic parameters against a protein database containing the S. coelicolor protein database as downloaded from Uniprot [39] on August 2023, the WT and mutant Salinispora protease, and predicted phage Alon open reading frames larger than 100 amino acids extracted using NCBI ORFFinder [40], and a list of common lab contaminants.

Infection experiments in liquid cultures with exogenously added supernatant

Spores of S. coelicolor M1146 not encoding WT Salinispora protease (Table S3 in S1 File, strain 2) were added to 750 μL of DNB MMC in 9 culture tubes of 15 mL at a concentration of 3 × 107 CFU/mL, along with phage Alon at MOI = 0.1 and 10 μL of harvested supernatants from strains 5–7 (Table S3 in S1 File) in biological triplicates and incubated at 30°C for 48 h. Following incubation phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters. Phage titer was then measured by plaque assay.

Selection for phages that escape the antiphage activity of the Salinispora protease

Three biological replicates of each phage (Alon or Tapuz) were amplified from single plaques on S. coelicolor M145. Each biological replicate of the phage was amplified on S. coelicolor Strains 5 and 6 (Table S3 in S1 File) expressing the WT Salinispora protease or the catalytically inactive S219A mutant, each in three biological replicates, as well. The phage amplification was set up similarly to the infection experiment of S. coelicolor with phages in liquid culture, but a higher volume and a variable incubation time was used, as described herby.

Round 1: Spores of S. coelicolor encoding WT Salinispora protease and mutant S219A Salinispora protease (Table S3 in S1 File, strains 5–6) were added in biological triplicates to 1.5 mL of DNB MMC in 6 culture tubes of 15 mL at a concentration of 3 × 107 CFU/mL, along with phage Alon or phage Tapuz at MOI = 0.1 and incubated at 30°C for 39 h. Following incubation, phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters and phage titer was then measured by plaque assay.

Round 2: for phage Alon or phage Tapuz, three phage stocks that were amplified over Round 1 on S. coelicolor expressing WT Salinispora protease were added in 1/10 of the total volume into 1.5 mL of DNB MMC in 6 culture tubes (3 of S. coelicolor expressing WT Salinispora protease and 3 expressing mutant protease) at a concentration of 3 × 107 CFU/mL. The amplification on S. coelicolor expressing WT Salinispora proteas was used for escaper isolation while the amplification over on S. coelicolor expressing mutant S219A Salinispora protease was used as a control to assess escaper phenotype evolution. MOI was varied depending on the phage stock and ranged between 0.001 and 0.1. As a control, one phage stock amplified over Round 1 on S. coelicolor expressing mutant Salinispora protease (S219A) was added in MOI 0.1 and 0.001 for phage Alon and Tapuz, respectively, to two tubes with spores of S. coelicolor expressing WT and S219A mutant Salinispora protease at a concentration of 3 × 107 CFU/mL. All tubes were incubated at 30°C for 50 h. Following incubation, phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters and phage titer was then measured by plaque assay.

Round 3: for phage Alon or phage Tapuz, three phage stocks amplified over Round 2 on S. coelicolor expressing WT Salinispora protease were added in 0.1 and 0.01 MOI for phage Alon and Tapuz, respectively, into 1.5 mL of DNB MMC in 6 culture tubes (3 of S. coelicolor expressing WT Salinispora protease and 3 expressing mutant protease) at a concentration of 3 × 107 CFU/mL. As a control, one phage stock amplified over Round 2 on S. coelicolor expressing mutant Salinispora protease (S219A) was added in MOI 0.1 to two tubes with spores of S. coelicolor expressing WT and S219A mutant Salinispora protease at a concentration of 3 × 107 CFU/mL. All tubes were incubated at 30°C for 44 h. Following incubation, phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters and phage titer was then measured by plaque assay.

For each of Round 2 and Round 3, phages that were amplified in liquid culture on S. coelicolor expressing WT Salinispora protease were plated to obtain single plaques on S. coelicolor expressing WT Salinispora protease. Control phages that were amplified in liquid culture on S. coelicolor expressing S219A mutant protease were plated on S. coelicolor expressing S219A mutant Salinispora protease. Except for the bacterial strain expressing Salinispora protease, single plaque plating was as described above: phage stocks were serially diluted and added to a 100 μL spore suspension of S. coelicolor (expressing WT or S219A Salinispora protease at 108 CFU/ mL) in 15 mL screw cap tubes. 5 mL of DNB MMC with 0.5% (w/v) agar at 50°C were then added and the resulting phage/spore suspension was mixed and plated on 100 × 15 mm plates with 20 mL DNB 2% (w/v) agar. The plates were incubated overnight at 30°C. Single plaques were picked with a pipette tip into 120 μL phage buffer.

Half of the single plaque suspension was used for infection in liquid culture with S. coelicolor expressing WT Salinispora protease and half was used for infection in liquid culture with S. coelicolor expressing S219A mutant Salinispora protease at a spore concentration of 3 × 107 CFU/mL. Total volume in DNB MMC was 1.5 mL and incubation was for two days. Following incubation, phages were harvested by pelleting bacterial cells at 3200 g at 4°C for 30 min, followed by filtration through 0.2 μ cellulose acetate filters and phage titer was then measured by plaque assay. Phage DNA was harvested from single plaque thus amplified in liquid culture on S. coelicolor expressing WT protease if the titer was < l0x reduced compared with the same single plaque suspension amplified on S. coelicolor expressing mutant S219A Salinispora protease. Such escaper phenotype was markedly different than the > 100X titer reduction commonly observed for WT phages Alon and Tapuz (Fig S2 in S1 File). Phage DNA sequencing and mutation analysis was performed as previously reported [21].

Phage purification by CsCl gradient

Phages Alon, Dagobah and Kromp were amplified on 3 plates of 150 × 15 mm dimensions each of S. coelicolor M145 to obtain 40 mL stocks of 1 × 1011 PFU/mL (Alon and Dagobah) and 2 × 1010 PFU/mL (Kromp). Phage purification was as previously reported [41], with modifications as described hereby. Phages were pelleted at 25,000 g at 4°C for 2 h. The pellet was resuspended with 0.5 mL of phage buffer and loaded on CsCl step gradients (2 ml of ρ = 1.3, 3 ml of ρ = 1.4, 3 ml of ρ = 1.5, 2 ml of ρ = 1.7; all in phage buffer) formed in open-top polyclear ultracentrifugation tubes (Seton Scientific). The gradients were centrifuged in an SW41 rotor (Beckman) at 25,000 rpm and 4°C for 2 h and the phage bands collected by needle side-puncture. Buffer exchange for the extracted phages was done using Amicon 4 mL centrifugal filters (10 kDa molecular weight cutoff) in steps reducing ionic strength. First, 3 M NaCl in phage buffer was added followed by 3200 g at 4°C for 15 min and the flowthrough was removed. 2 M NaCl in phage buffer was then added followed by 3200 g at 4°C for 15 min and the flowthrough was removed. 1 M NaCl in phage buffer was then added followed by 3200 g at 4°C for 15 min and the flowthrough was removed. Phage buffer was then added followed by 3200 g at 4°C for 15 min and the flowthrough was removed. Finally, phage buffer was added followed by 3200 g at 4°C for 60 min for a final purified phage volume of 100 μL.

Purified phage incubation with concentrated supernatant

Purified phage, phage buffer and concentrated supernatant were mixed in PCR tubes as follows: 4 μL of purified phage (Alon, Dagobah or Kromp, purified as described in the section above discussing CsCl gradient), 2 μL of concentrated supernatant (from S. coelicolor expressing WT Salinispora protease or mutant S219A Salinispora protease, each in three biological replicates; harvested as described in the section titled ‘supernatant harvest from S. coelicolor cultures’) and 2 μL of phage buffer. Samples were incubated without shaking at the following temperature gradient: 3 h at 30°C, 3 h at 25°C, 3 h at 20°C, 3 h at 15°C, 7 h at 10°C and 7 h at 4°C. Phage titers were counted by plaque assay as described above. Complete phage particles with and without DNA were counted from electron microscopy images following negative staining as described below.

Negative staining and electron microscopy imaging

For negative staining, formvar and carbon-coated copper grids (300 mesh, Electron Microscopy Sciences) were glow discharged in an Evactron CombiClean Decontaminator (XEI Scientific) for 2 min at 0.067 mbar (air) and 18 W. 3 μL of the phage sample was then directly applied to the grid, incubated for 1 min and blotted with filter paper (Whatman Grade 1). The grid was briefly washed on a drop of water and blotted with filter paper. Staining was performed by touching a 10 μL drop of 2% (w/v) uranyl acetate, followed by blotting with filter paper. This step was repeated once more. Then the grid was placed on a third 10 μL drop of 2% (w/v) uranyl acetate for 1 min. Finally, the grid was blotted with filter paper and air dried. Imaging was performed using a Tecnai Spirit (Bio Twin) transmission electron microscope (Thermo Fisher Scientific) at an accelerating voltage of 120 kV and a Gatan OneView camera.

Supporting information

S1 File.

Figure S1. Mass spectrometry (MS) analysis indicates presence of the catalytically inactive protease mutant in supernatants. Figure S2. Titers of phages Alon and Tapuz following infection with S. coelicolor expressing the WT Salinispora protease (WT) or a catalytically inactive mutant of the protease. Figure S3. Phage Alon variants selected on bacteria expressing the WT Salinispora protease (Escaper) or catalytically inactive protease (Control). Figure S4. Salinispora protease-dependent DNA loss in phage Alon incubated with concentrated supernatant from S. coelicolor cells expressing WT Salinispora protease but not mutant protease. Figure S5. Time course experiment with phage Tapuz showing how phage titers change over time in an infection experiment of S. coelicolor encoding the WT Salinispora protease (red) or a negative control not encoding the protease (blue). Table S2. Phages used in this study. Table S3. Bacterial strains used in this study. Table S4. Plasmids used in this study.

https://doi.org/10.1371/journal.pone.0332566.s001

(DOCX)

S2 File. Plasmid map of 15_2517459620_Gib_in_pCAP03.

https://doi.org/10.1371/journal.pone.0332566.s002

(GBK)

S3 File. Plasmid map of 15_2517459620_S219A_Gib_in_pCAP03.

https://doi.org/10.1371/journal.pone.0332566.s003

(GBK)

S5 File. Plasmid map of 3_actinomycin-50-bp-homo-capture-vector-pCAP03.

https://doi.org/10.1371/journal.pone.0332566.s005

(GBK)

Acknowledgments

We thank members of the Sorek lab for constructive discussion. We thank the Bar-Shir lab and the Stern-Ginossar lab for sharing their facilities for conducting this research.

References

  1. 1. Doron S, Melamed S, Ofir G, Leavitt A, Lopatina A, Keren M, et al. Systematic discovery of antiphage defense systems in the microbial pangenome. Science. 2018;359(6379):eaar4120. pmid:29371424
  2. 2. Gao L, Altae-Tran H, Böhning F, Makarova KS, Segel M, Schmid-Burgk JL, et al. Diverse enzymatic activities mediate antiviral immunity in prokaryotes. Science. 2020;369(6507):1077–84. pmid:32855333
  3. 3. Millman A, Melamed S, Leavitt A, Doron S, Bernheim A, Hör J, et al. An expanded arsenal of immune systems that protect bacteria from phages. Cell Host Microbe. 2022;30(11):1556-1569.e5. pmid:36302390
  4. 4. Georjon H, Bernheim A. The highly diverse antiphage defence systems of bacteria. Nat Rev Microbiol. 2023;21(10):686–700. pmid:37460672
  5. 5. Tal N, Sorek R. SnapShot: Bacterial immunity. Cell. 2022;185(3):578-578.e1. pmid:35120666
  6. 6. Hoque MM, Naser IB, Bari SMN, Zhu J, Mekalanos JJ, Faruque SM. Quorum Regulated Resistance of Vibrio cholerae against Environmental Bacteriophages. Sci Rep. 2016;6:37956. pmid:27892495
  7. 7. Castillo D, Rørbo N, Jørgensen J, Lange J, Tan D, Kalatzis PG, et al. Phage defense mechanisms and their genomic and phenotypic implications in the fish pathogen Vibrio anguillarum. FEMS Microbiol Ecol. 2019;95(3):10.1093/femsec/fiz004. pmid:30624625
  8. 8. Eckhard U, Schönauer E, Nüss D, Brandstetter H. Structure of collagenase G reveals a chew-and-digest mechanism of bacterial collagenolysis. Nat Struct Mol Biol. 2011;18(10):1109–14. pmid:21947205
  9. 9. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FTD, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361(10):968–79. pmid:19726771
  10. 10. Ramírez-Larrota JS, Eckhard U. An Introduction to Bacterial Biofilms and Their Proteases, and Their Roles in Host Infection and Immune Evasion. Biomolecules. 2022;12(2):306. pmid:35204806
  11. 11. Kato J- y., Chi W-J, Ohnishi Y, Hong S-K, Horinouchi S. Transcriptional control by A-factor of two trypsin genes in Streptomyces griseus. Journal of Bacteriology. 2005;187:286–95.
  12. 12. Kim IS, Lee KJ. Physiological roles of leupeptin and extracellular proteases in mycelium development of Streptomyces exfoliatus SMF13. Microbiology (Reading). 1995;141 (Pt 4):1017–25. pmid:7773379
  13. 13. Teufel F, Almagro Armenteros JJ, Johansen AR, Gíslason MH, Pihl SI, Tsirigos KD, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40(7):1023–5. pmid:34980915
  14. 14. Gomez-Escribano JP, Bibb MJ. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb Biotechnol. 2011;4(2):207–15. pmid:21342466
  15. 15. Hardy A, Sharma V, Kever L, Frunzke J. Genome Sequence and Characterization of Five Bacteriophages Infecting Streptomyces Coelicolor and Streptomyces Venezuelae: Alderaan, Coruscant, Dagobah, Endor1 and Endor2. Viruses. 2020;12(10):1065. pmid:3297769
  16. 16. Russell DA, Hatfull GF. PhagesDB: the actinobacteriophage database. Bioinformatics. 2017;33(5):784–6. pmid:28365761
  17. 17. Zhang JJ, Tang X, Moore BS. Genetic platforms for heterologous expression of microbial natural products. Nat Prod Rep. 2019;36(9):1313–32. pmid:31197291
  18. 18. Matthews BW, Sigler PB, Henderson R, Blow DM. Three-dimensional structure of tosyl-alpha-chymotrypsin. Nature. 1967;214(5089):652–6. pmid:6049071
  19. 19. Morrison H. (2021). Chymotrypsin. In Enzyme Active Sites and their Reaction Mechanisms. pp. 41–4.
  20. 20. Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochim Biophys Acta. 2004;1698(1):77–86. pmid:15063317
  21. 21. Stokar-Avihail A, Fedorenko T, Hör J, Garb J, Leavitt A, Millman A, et al. Discovery of phage determinants that confer sensitivity to bacterial immune systems. Cell. 2023;186(9):1863-1876.e16. pmid:37030292
  22. 22. Gilchrist CLM, Chooi Y-H. clinker & clustermap.js: automatic generation of gene cluster comparison figures. Bioinformatics. 2021;37(16):2473–5. pmid:33459763
  23. 23. Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9. pmid:34265844
  24. 24. van Kempen M, Kim SS, Tumescheit C, Mirdita M, Lee J, Gilchrist CLM, et al. Fast and accurate protein structure search with Foldseek. Nat Biotechnol. 2024;42(2):243–6. pmid:37156916
  25. 25. Sayers EW, Beck J, Bolton EE, Brister JR, Chan J, Connor R, et al. Database resources of the National Center for Biotechnology Information in 2025. Nucleic Acids Res. 2025;53(D1):D20–9. pmid:39526373
  26. 26. Zheng W, Wang F, Taylor NMI, Guerrero-Ferreira RC, Leiman PG, Egelman EH. Refined Cryo-EM Structure of the T4 Tail Tube: Exploring the Lowest Dose Limit. Structure. 2017;25(9):1436-1441.e2. pmid:28757144
  27. 27. Leforestier A, Livolant F. The bacteriophage genome undergoes a succession of intracapsid phase transitions upon DNA ejection. J Mol Biol. 2010;396(2):384–95. pmid:19944702
  28. 28. Román-Ponce B, Millán-Aguiñaga N, Guillen-Matus D, Chase AB, Ginigini JGM, Soapi K, et al. Six novel species of the obligate marine actinobacterium Salinispora, Salinispora cortesiana sp. nov., Salinispora fenicalii sp. nov., Salinispora goodfellowii sp. nov., Salinispora mooreana sp. nov., Salinispora oceanensis sp. nov. and Salinispora vitiensis sp. nov., and emended description of the genus Salinispora. Int J Systematic Evolutionary Microbiology. 2020;70:4668–82.
  29. 29. Manteca A, Alvarez R, Salazar N, Yagüe P, Sanchez J. Mycelium differentiation and antibiotic production in submerged cultures of Streptomyces coelicolor. Appl Environ Microbiol. 2008;74(12):3877–86. pmid:18441105
  30. 30. Barbuto Ferraiuolo S, Cammarota M, Schiraldi C, Restaino OF. Streptomycetes as platform for biotechnological production processes of drugs. Appl Microbiol Biotechnol. 2021;105(2):551–68. pmid:33394149
  31. 31. Kronheim S, Daniel-Ivad M, Duan Z, Hwang S, Wong AI, Mantel I, et al. A chemical defence against phage infection. Nature. 2018;564(7735):283–6. pmid:30518855
  32. 32. Luthe T, Kever L, Hänsch S, Hardy A, Tschowri N, Weidtkamp-Peters S, et al. Streptomyces development is involved in the efficient containment of viral infections. Microlife. 2023;4:uqad002. pmid:37223739
  33. 33. Mordret E, Hervé A, Vaysset H, Clabby T, Tesson F, Shomar H, et al. Protein and genomic language models chart a vast landscape of antiphage defenses. bioRxiv. 2025.
  34. 34. Shomar H, Tesson F, Guillaume M, Ongenae V, Le Bot M, Georjon H, et al. A family of lanthipeptides with anti-phage function. bioRxiv. 2024.
  35. 35. Shepherd MD, Kharel MK, Bosserman MA, Rohr J. Laboratory maintenance of Streptomyces species. Curr Protoc Microbiol. 2010;Chapter 10:Unit 10E.1. pmid:20812215
  36. 36. Zhang JJ, Yamanaka K, Tang X, Moore BS. Direct cloning and heterologous expression of natural product biosynthetic gene clusters by transformation-associated recombination. Chemical and Synthetic Biology Approaches To Understand Cellular Functions - Part A. 2019. pp. 87–110.
  37. 37. Figurski DH, Helinski DR. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A. 1979;76(4):1648–52. pmid:377280
  38. 38. Schrodinger LLC. The PyMOL Molecular Graphics System, Version 1.8. 2015.
  39. 39. UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–31. pmid:36408920
  40. 40. Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50(D1):D20–6. pmid:34850941
  41. 41. Hör J, Wolf SG, Sorek R. Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly. Nature. 2024;631(8022):850–6. pmid:39020165